XML 34 R24.htm IDEA: XBRL DOCUMENT v3.25.2
REVERSE MERGER (Tables)
 3 Months Ended
Jun. 30, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
SCHEDULE OF PURCHASE PRICE ALLOCATION

The estimated allocation of the purchase price of the assets acquired and liabilities assumed for the acquisition by Phytanix Bio of Protagenic Therapeutics, Inc. via the reverse acquisition are set forth below:

 

Purchase Price Allocation of Protagenic Therapeutics, Inc.

 SCHEDULE OF PURCHASE PRICE ALLOCATION

      
Current assets – cash and prepaid  $1,029,985 
Intangible assets – in process research and development and assembled workforce   2,093,228 
Fixed assets   76,550 
Accounts payable and accrued expenses   (857,504)
Purchase price  $2,342,259